We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genes Discovered Influence Risk of Developing Leprosy

By LabMedica International staff writers
Posted on 25 Mar 2015
Leprosy, a chronic dermatological and neurological disease, is caused by infection with Mycobacterium leprae, and its manifestation, progression and prognosis are strongly associated with the proficiency of the patient's immune system.

The ability to predict the risk of contracting leprosy can help guide decisions made by public healthcare policymakers when drafting preventative measures for high-risk medical staff working in close contact with leprosy patients. More...


Scientists at the Genome Institute of Singapore (A*STAR, Singapore) conducted a three-stage genome-wide association studies (GWAS) of leprosy in the Chinese population. The genome-wide discovery analysis (stage 1) involved two independent data sets: a previously published GWAS data set of 706 leprosy cases, 1,225 healthy controls and 4,362 individuals with immune-related diseases as population controls from northern China of Chinese Han descent and a new unpublished data set of 842 leprosy cases and 925 controls from northern and southern China.

The second independent study was genotyped using Human 660K-Quad BeadChips (Illumina; San Diego, CA, USA). The scientists discovered six new susceptibility loci, and further gene prioritization analysis of these loci implicated Basic Leucine Zipper Transcription Factor, ATF-Like 3 (BATF3), Coiled-Coil Domain Containing 88B (CCDC88B) and Class II, major histocompatibility complex, transactivator-Suppressor of cytokine signaling 1 (CIITA-SOCS1) as new susceptibility genes for leprosy. They found the same genes linked to leprosy susceptibility also affect the level of aggression expressed by the immune system observed in autoimmune and inflammatory diseases. A person with an overly-aggressive immune system may have a good defense against infection, but stands a higher risk of developing autoimmune diseases where one's own white blood cells attack healthy cells that can lead to death in severe cases.

Jianjun Liu, PhD, a professor and lead author of the study, said, “Although commonly viewed as a medieval affliction, leprosy remains a major health problem in developing countries, claiming over 200,000 new patients worldwide annually with two to three million people permanently disabled. With the discovery of more gene variants that affect the risk of developing leprosy, we can develop better diagnostic, treatment and preventive strategies to one day eradicate leprosy permanently.” The study was published online on February 3, 2015, in the journal Nature Genetics.

Related Links:

Genome Institute of Singapore
Illumina



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.